The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus

Table 4

Multiple linear regression analysis of T cell subsets and cytokines adjusted with BMI.

	Group		SE	Adjust
LgIL-6	DM	0 (ref.)
	NG	-0.45	0.19	-0.39	-2.37	0.02
	IGR	-0.28	0.21	-0.22	-1.35	0.18
LgINFγ	DM	0 (ref.)
	NG	-0.09	0.06	-0.27	-1.64	0.11
	IGR	-0.12	0.06	-0.34	-2.10	0.04
LgTNFα	DM	0 (ref.)
	NG	-0.00	0.09	-0.00	-0.01	0.99
	IGR	-0.14	0.10	-0.23	-1.37	0.18
LgIL-4	DM	0 (ref.)
	NG	-0.03	0.06	-0.08	-0.49	0.63
	IGR	-0.09	0.07	-0.22	-1.32	0.19
LgIL-2	DM	0 (ref.)
	NG	-0.03	0.04	-0.12	-0.68	0.50
	IGR	-0.07	0.04	-0.28	-1.71	0.09
LgIL-10	DM	0 (ref.)
	NG	-0.14	0.04	-0.48	-3.10	0.00
	IGR	-0.13	0.05	-0.40	-2.68	0.01
CD4	DM	0 (ref.)
	NG	-7.31	3.03	-0.41	-2.42	0.02
	IGR	-7.28	3.32	-0.36	-2.19	0.03
CD8	DM	0 (ref.)
	NG	5.29	3.02	0.30	1.75	0.09
	IGR	3.76	3.31	0.19	1.14	0.26
LgCD4/CD8	DM	0 (ref.)
	NG	-0.18	0.07	-0.41	-2.45	0.02
	IGR	-0.13	0.08	-0.27	-1.67	0.10

NDM: nondiabetes mellitus; IFG: impaired fasting glucose; DM: diabetes mellitus.